Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS Med. 2010 Jan;7(1):e1000208. doi: 10.1371/journal.pmed.1000208. Epub 2010 Jan 5.

Are patents impeding medical care and innovation?

Author information

1
Faculty of Law, McGill University, Montreal, Quebec, Canada. richard.gold2@mcgill.ca

Abstract

BACKGROUND TO THE DEBATE:

Pharmaceutical and medical device manufacturers argue that the current patent system is crucial for stimulating research and development (R&D), leading to new products that improve medical care. The financial return on their investments that is afforded by patent protection, they claim, is an incentive toward innovation and reinvestment into further R&D. But this view has been challenged in recent years. Many commentators argue that patents are stifling biomedical research, for example by preventing researchers from accessing patented materials or methods they need for their studies. Patents have also been blamed for impeding medical care by raising prices of essential medicines, such as antiretroviral drugs, in poor countries. This debate examines whether and how patents are impeding health care and innovation.

PMID:
20052274
PMCID:
PMC2795161
DOI:
10.1371/journal.pmed.1000208
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center